Advanced in Appendix Cancer

Dr. Alok Khorana

Oncology
Cleveland Clinic
Cleveland Clinic Main Campus
10201 Carnegie Avenue, 
Cleveland, OH 
On Staff At
Offers Telehealth
Advanced in Appendix Cancer
Cleveland Clinic
Cleveland Clinic Main Campus
10201 Carnegie Avenue, 
Cleveland, OH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Alok Khorana is an Oncologist in Cleveland, Ohio. Dr. Khorana is rated as an Advanced provider by MediFind in the treatment of Appendix Cancer. His top areas of expertise are Venous Thromboembolism (VTE), Pancreatic Cancer, Colorectal Cancer, Pancreatectomy, and Endoscopy.

His clinical research consists of co-authoring 264 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Residency
Millard Fillmore Gates Circle Hospital / Kaleida Health
Specialties
Oncology
Licenses
Internal Medicine in NY
Board Certifications
American Board Of Internal Medicine, 2002
Fellowships
University of Rochester Medical Center
Hospital Affiliations
Hillcrest Hospital
Cleveland Clinic Avon Hospital
Cleveland Clinic
Akron General Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Ambetter
  • EPO
  • HMO
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
AultCare
  • PPO
CareSource
  • HMO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
CommuniCare Advantage
  • MEDICARE SNP
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medical Mutual
  • HMO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
Paramount
  • EPO
  • HMO
  • INDEMNITY
  • PPO
Primetime Health Plan
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE PART D
Provider Partners Health Plan
  • MEDICARE SNP
SummaCare
  • HMO
  • PPO
The Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Univera Healthcare
  • INSURANCE PLAN
  • MEDICARE MAPD
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 19 Less Insurance Carriers -

Locations

Cleveland Clinic Main Campus
10201 Carnegie Avenue, Cleveland, OH 44106
Call: 866-223-8100

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Dose Escalation and Cohort Expansion Study of DKN-01 in Combination With Gemcitabine and Cisplatin in Patients With Advanced Carcinoma Primary to the Intra- or Extra-hepatic Biliary System or Gallbladder
A Dose Escalation and Cohort Expansion Study of DKN-01 in Combination With Gemcitabine and Cisplatin in Patients With Advanced Carcinoma Primary to the Intra- or Extra-hepatic Biliary System or Gallbladder
Enrollment Status: Completed
Publish Date: August 03, 2025
Intervention Type: Drug
Study Phase: Phase 1
A Randomized, Double-blind, Placebo-controlled, Active Comparator Phase 2/3 Study of Tucatinib in Combination With Trastuzumab, Ramucirumab, and Paclitaxel in Subjects With Previously Treated, Locally-advanced Unresectable or Metastatic HER2+ Gastric or Gastroesophageal Junction Adenocarcinoma (GEC)
A Randomized, Double-blind, Placebo-controlled, Active Comparator Phase 2/3 Study of Tucatinib in Combination With Trastuzumab, Ramucirumab, and Paclitaxel in Subjects With Previously Treated, Locally-advanced Unresectable or Metastatic HER2+ Gastric or Gastroesophageal Junction Adenocarcinoma (GEC)
Enrollment Status: Completed
Publish Date: January 22, 2025
Intervention Type: Drug, Other
Study Drugs: Tucatinib, Trastuzumab, Ramucirumab, Paclitaxel
Study Phase: Phase 2/Phase 3
A Multicenter, Randomized, Open-label, 3-Arm Phase 3 Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer
A Multicenter, Randomized, Open-label, 3-Arm Phase 3 Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer
Enrollment Status: Completed
Publish Date: December 21, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Phase III Multicenter Open-label Randomized Trial to Evaluate Efficacy and Safety of Folfirinox (FFX) Versus Combination of CPI-613 With Modified Folfirinox (mFFX) in Patients With Metastatic Adenocarcinoma of the Pancreas
A Phase III Multicenter Open-label Randomized Trial to Evaluate Efficacy and Safety of Folfirinox (FFX) Versus Combination of CPI-613 With Modified Folfirinox (mFFX) in Patients With Metastatic Adenocarcinoma of the Pancreas
Enrollment Status: Completed
Publish Date: January 03, 2023
Intervention Type: Drug
Study Drugs: CPI 613, mFolfirinox, Folfirinox
Study Phase: Phase 3
A Randomized, Phase II Study Of Weight-Based Versus Standard Dose Enoxaparin Thromboprophylaxis In High-Risk Hospitalized Cancer Patients
A Randomized, Phase II Study Of Weight-Based Versus Standard Dose Enoxaparin Thromboprophylaxis In High-Risk Hospitalized Cancer Patients
Enrollment Status: Completed
Publish Date: July 08, 2021
Intervention Type: Drug
Study Drug: Enoxaparin
Study Phase: Phase 2
A Prospective, Multinational, Multi-Center, Phase 2, Single-Arm, Open-Label Study Evaluating the Efficacy, Safety and Tolerability of siG12D-LODER in Combination With Standard of Care Chemotherapy in the Treatment of Patients With Locally Advanced Pancreatic Cancer
A Prospective, Multinational, Multi-Center, Phase 2, Single-Arm, Open-Label Study Evaluating the Efficacy, Safety and Tolerability of siG12D-LODER in Combination With Standard of Care Chemotherapy in the Treatment of Patients With Locally Advanced Pancreatic Cancer
Enrollment Status: Unknown
Publish Date: July 02, 2021
Intervention Type: Drug
Study Drugs: siG12D-LODER, Gemcitabine+Nab-Paclitaxel, Folfirinox
Study Phase: Phase 2
View 5 Less Clinical Trials

263 Total Publications

Cabozantinib and thromboembolism in patients with cancer: a systematic review, meta-analysis and retrospective study.
Cabozantinib and thromboembolism in patients with cancer: a systematic review, meta-analysis and retrospective study.
Journal: Blood advances
Published: August 12, 2025
View All 263 Publications
Similar Doctors
Smitha Krishnamurthi
Advanced in Appendix Cancer
Dr. Smitha Krishnamurthi
Oncology
Advanced in Appendix Cancer
Dr. Smitha Krishnamurthi
Oncology

Cleveland Clinic Main Campus

10201 Carnegie Avenue, 
Cleveland, OH 
 (0.3 miles away)
866-223-8100
Experience:
37+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Smitha Krishnamurthi is an Oncologist in Cleveland, Ohio. Dr. Krishnamurthi has been practicing medicine for over 37 years and is rated as a Distinguished provider by MediFind in the treatment of Appendix Cancer. Her top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Lynch Syndrome, Pancreaticoduodenectomy, and Hepato-Pancreato-Biliary Surgery.

Advanced in Appendix Cancer
Dr. David Bajor
Hematology Oncology | Hematology | Oncology
Advanced in Appendix Cancer
Dr. David Bajor
Hematology Oncology | Hematology | Oncology

University Hospitals Medical Group Inc

11100 Euclid Ave, 
Cleveland, OH 
 (0.9 miles away)
Languages Spoken:
English
See accepted insurances
Offers Telehealth

David Bajor is a Hematologist Oncology specialist and a Hematologist in Cleveland, Ohio. Dr. Bajor is rated as a Distinguished provider by MediFind in the treatment of Appendix Cancer. His top areas of expertise are Colorectal Cancer, Pancreatic Cancer, Familial Pancreatic Cancer, Pancreaticoduodenectomy, and Awake Craniotomy.

Advanced in Appendix Cancer
Dr. Suresh D. Mendpara
Hematology Oncology | Hematology | Oncology
Advanced in Appendix Cancer
Dr. Suresh D. Mendpara
Hematology Oncology | Hematology | Oncology

University Primary Care Practices Inc

970 E Washington St, Suite 4d, 
Medina, OH 
 (27.5 miles away)
330-722-5420
Languages Spoken:
English, Hindi, Sanskrit, Urdu
See accepted insurances
Accepting New Patients

Suresh Mendpara is a Hematologist Oncology specialist and a Hematologist in Medina, Ohio. Dr. Mendpara is rated as a Distinguished provider by MediFind in the treatment of Appendix Cancer. His top areas of expertise are Gastric Lymphoma, Colorectal Cancer, Familial Colorectal Cancer, and Non-Hodgkin Lymphoma. Dr. Mendpara is currently accepting new patients.

VIEW MORE APPENDIX CANCER DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Khorana's expertise for a condition
ConditionClose
  • Elite
  • Colorectal Cancer
    Dr. Khorana is
    Elite
    . Learn about Colorectal Cancer.
    See more Colorectal Cancer experts
  • Pancreatic Cancer
    Dr. Khorana is
    Elite
    . Learn about Pancreatic Cancer.
    See more Pancreatic Cancer experts
  • Venous Thromboembolism (VTE)
    Dr. Khorana is
    Elite
    . Learn about Venous Thromboembolism (VTE).
    See more Venous Thromboembolism (VTE) experts
  • Distinguished
  • Cholangiocarcinoma (Bile Duct Cancer)
    Dr. Khorana is
    Distinguished
    . Learn about Cholangiocarcinoma (Bile Duct Cancer).
    See more Cholangiocarcinoma (Bile Duct Cancer) experts
  • Deep Vein Thrombosis
    Dr. Khorana is
    Distinguished
    . Learn about Deep Vein Thrombosis.
    See more Deep Vein Thrombosis experts
  • Familial Colorectal Cancer
    Dr. Khorana is
    Distinguished
    . Learn about Familial Colorectal Cancer.
    See more Familial Colorectal Cancer experts
  • Familial Pancreatic Cancer
    Dr. Khorana is
    Distinguished
    . Learn about Familial Pancreatic Cancer.
    See more Familial Pancreatic Cancer experts
  • Lynch Syndrome
    Dr. Khorana is
    Distinguished
    . Learn about Lynch Syndrome.
    See more Lynch Syndrome experts
  • Mesenteric Venous Thrombosis
    Dr. Khorana is
    Distinguished
    . Learn about Mesenteric Venous Thrombosis.
    See more Mesenteric Venous Thrombosis experts
View All 7 Distinguished Conditions
  • Advanced
  • Anal Cancer
    Dr. Khorana is
    Advanced
    . Learn about Anal Cancer.
    See more Anal Cancer experts
  • Appendix Cancer
    Dr. Khorana is
    Advanced
    . Learn about Appendix Cancer.
    See more Appendix Cancer experts
  • Gallbladder Adenocarcinoma
    Dr. Khorana is
    Advanced
    . Learn about Gallbladder Adenocarcinoma.
    See more Gallbladder Adenocarcinoma experts
  • Gallbladder Cancer
    Dr. Khorana is
    Advanced
    . Learn about Gallbladder Cancer.
    See more Gallbladder Cancer experts
  • Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
    Dr. Khorana is
    Advanced
    . Learn about Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET).
    See more Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) experts
  • Gastroesophageal Junction Cancer
    Dr. Khorana is
    Advanced
    . Learn about Gastroesophageal Junction Cancer.
    See more Gastroesophageal Junction Cancer experts
View All 11 Advanced Conditions
  • Experienced
  • Agranulocytosis
    Dr. Khorana is
    Experienced
    . Learn about Agranulocytosis.
    See more Agranulocytosis experts
  • Ampullary Cancer
    Dr. Khorana is
    Experienced
    . Learn about Ampullary Cancer.
    See more Ampullary Cancer experts
  • Anemia
    Dr. Khorana is
    Experienced
    . Learn about Anemia.
    See more Anemia experts
  • Astrocytoma
    Dr. Khorana is
    Experienced
    . Learn about Astrocytoma.
    See more Astrocytoma experts
  • Brain Tumor
    Dr. Khorana is
    Experienced
    . Learn about Brain Tumor.
    See more Brain Tumor experts
  • Breast Cancer
    Dr. Khorana is
    Experienced
    . Learn about Breast Cancer.
    See more Breast Cancer experts
View All 37 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.